KMDA
Kamada Ltd.
KMDA trails on the overall score without a compensating advantage in the available component scores.
LLY
Eli Lilly and Company
LLY has the edge over KMDA overall, supported by stronger valuation and stronger fundamentals.
KMDA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
KMDA's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
KMDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $5.76 | -29% |
| Forward | 18x | $8.13 | — |
| Fair | 21x | $7.96 | -2.1% |
| Current | 21x | $8.13 | — |
| Expensive | 38x | $14.26 | +75% |
Historical ranges are pointers, not guarantees.
KMDA has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
KMDA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect KMDA's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over KMDA on the outlook, with more favorable earnings and profitability expectations.
KMDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.45 | +18% |
| Q2 2026 | $0.38 | +15% |
| Q1 2026 | $0.35 | +25% |
| Q4 2025 | $0.35 | +40% |
| Q3 2025 | $0.35 | +25% |
| Q2 2025 | $0.33 | +22% |
| Q1 2025 | $0.28 | +22% |
| Q4 2024 | $0.25 | +67% |
| Q3 2024 | $0.28 | +133% |
KMDA's earnings per share have fallen from their peak: $0.38 over the past year, against $0.85 in late 2019.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over KMDA on earnings, with stronger typical year-over-year growth.
KMDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $54.9M | +23% |
| Q1 2026 | $45.2M | +2.8% |
| Q4 2025 | $44.7M | +15% |
| Q3 2025 | $47M | +13% |
| Q2 2025 | $44.8M | +5.4% |
| Q1 2025 | $44M | +17% |
| Q4 2024 | $39M | +7.1% |
| Q3 2024 | $41.7M | +10% |
KMDA's revenue has grown year over year for 10 quarters in a row: $55M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +1.5 points |
| Q1 2026 | 15% | -2.3 points |
| Q4 2025 | 8% | -5.1 points |
| Q3 2025 | 17% | +3.9 points |
| Q2 2025 | 16% | +2.5 points |
| Q1 2025 | 18% | +7 points |
| Q4 2024 | 13% | +5.4 points |
| Q3 2024 | 13% | +1.2 points |
KMDA's operating margin was 17% last quarter, up 1.5 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over KMDA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over KMDA on profitability, with a higher operating margin.
KMDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $16M | +166% |
| Q1 2026 | -$1.3M | +$717K |
| Q4 2025 | $5M | -34% |
| Q3 2025 | $6.8M | -66% |
| Q2 2025 | $6M | -45% |
| Q1 2025 | -$2M | -$319K |
| Q4 2024 | $7.5M | +207% |
| Q3 2024 | $20.1M | +$20.9M |
KMDA generated $26M in free cash flow over the past year, down 16% from the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over KMDA on cash flow, with more consistent year-over-year improvement.
KMDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -1.1M shares |
| 1 year | +2% | +1.1M shares |
| 3 years | +29% | +13.1M shares |
| 5 years | +24% | +11M shares |
| Available history | +39% | +16.3M shares |
KMDA has 58M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q3 2024 | — |
| Q2 2024 | — |
KMDA hasn't bought back shares in the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over KMDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
KMDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2024 | -2.1x | Net Cash |
KMDA has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
KMDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 41.1 | Neutral |
KMDA's weekly RSI is 53 (neutral) and its Stochastic is 41 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
KMDA PE vs Healthcare Sector
| Metric | KMDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 26x | 17% below |
| PE % | 52 | 29 | 23 pts above |
KMDA has the edge over LLY on valuation relative to its sector.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
KMDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.96 | 2.1% above |
| 20 week MA | $7.81 | 4.1% above |
| 50 week MA | $7.91 | 2.8% above |
| 100 week MA | $7.44 | 9.3% above |
| 200 week MA | $6.36 | 28% above |
KMDA is in an uptrend: it's above all five of its weekly moving averages, and 28% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
KMDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.84 | $6.60 | -3.5% |
| 2021 | $6.60 | $6.78 | +2.7% |
| 2022 | $6.78 | $3.92 | -42% |
| 2023 | $3.92 | $6.12 | +56% |
| 2024 | $6.12 | $5.92 | -3.3% |
| 2025 | $5.92 | $7.07 | +19% |
| 2026 YTD | $7.07 | $8.13 | +15% |
KMDA has finished lower in three of the last six years. It's up 15% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over KMDA on returns for 2026, with the stronger performance.